SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-023061
Filing Date
2021-07-01
Accepted
2021-07-01 08:56:29
Documents
14
Period of Report
2021-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nt10026444x7_8k.htm   iXBRL 8-K 41387
2 EXHIBIT 4.1 nt10026444x7_ex4-1.htm EX-4.1 1487248
3 EXHIBIT 10.1 nt10026444x7_ex10-1.htm EX-10.1 1463895
  Complete submission text file 0001140361-21-023061.txt   3723480

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA prah-20210701.xsd EX-101.SCH 3914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prah-20210701_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prah-20210701_pre.xml EX-101.PRE 16036
7 EXTRACTED XBRL INSTANCE DOCUMENT nt10026444x7_8k_htm.xml XML 4220
Mailing Address 4130 PARKLAKE AVENUE SUITE 400 RALEIGH NC 27612
Business Address 4130 PARKLAKE AVENUE SUITE 400 RALEIGH NC 27612 9197868200
PRA Health Sciences, Inc. (Filer) CIK: 0001613859 (see all company filings)

IRS No.: 463640387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36732 | Film No.: 211064220
SIC: 8731 Services-Commercial Physical & Biological Research